Literature DB >> 19131108

Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling.

Takashi Kimura1, John D Lueck, Peta J Harvey, Suzy M Pace, Noriaki Ikemoto, Marco G Casarotto, Robert T Dirksen, Angela F Dulhunty.   

Abstract

Alternative splicing of ASI residues (Ala(3481)-Gln(3485)) in the skeletal muscle ryanodine receptor (RyR1) is developmentally regulated: the residues are present in adult ASI(+)RyR1, but absent in the juvenile ASI(-)RyR1 which is over-expressed in adult myotonic dystrophy type 1 (DM1). Although this splicing switch may influence RyR1 function in developing muscle and DM1, little is known about the properties of the splice variants. We examined excitation-contraction (EC) coupling and the structure and interactions of the ASI domain (Thr(3471)-Gly(3500)) in the splice variants. Depolarisation-dependent Ca(2+) release was enhanced by >50% in myotubes expressing ASI(-)RyR1 compared with ASI(+)RyR1, although DHPR L-type currents and SR Ca(2+) content were unaltered, while ASI(-)RyR1 channel function was actually depressed. The effect on EC coupling did not depend on changes in ASI domain secondary structure. Probing RyR1 function with peptides possessing the ASI domain sequence indicated that the domain contributes to an inhibitory module in RyR1. The action of the peptide depended on a sequence of basic residues and their alignment in an alpha-helix adjacent to the ASI splice site. This is the first evidence that the ASI residues contribute to an inhibitory module in RyR1 that influences EC coupling. Implications for development and DM1 are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131108      PMCID: PMC2743929          DOI: 10.1016/j.ceca.2008.11.005

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  39 in total

1.  The three-dimensional structural surface of two beta-sheet scorpion toxins mimics that of an alpha-helical dihydropyridine receptor segment.

Authors:  Daniel Green; Suzi Pace; Suzanne M Curtis; Magdalena Sakowska; Graham D Lamb; Angela F Dulhunty; Marco G Casarotto
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  [Changes in muscular excitability and contractility caused by fatigue in Steinert's disease].

Authors:  G Siciliano; B Rossi; P Rosellini; A Muratorio
Journal:  Riv Neurol       Date:  1990 Nov-Dec

3.  Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.

Authors:  A Chu; M Díaz-Muñoz; M J Hawkes; K Brush; S L Hamilton
Journal:  Mol Pharmacol       Date:  1990-05       Impact factor: 4.436

4.  Mechanism of muscle wasting in myotonic dystrophy.

Authors:  R C Griggs; R Jozefowicz; W Kingston; K S Nair; B E Herr; D Halliday
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

5.  Ca2+ sparks are initiated by Ca2+ entry in embryonic mouse skeletal muscle and decrease in frequency postnatally.

Authors:  Lois G Chun; Christopher W Ward; Martin F Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2003-04-30       Impact factor: 4.249

6.  Total and sarcoplasmic reticulum calcium contents of skinned fibres from rat skeletal muscle.

Authors:  M W Fryer; D G Stephenson
Journal:  J Physiol       Date:  1996-06-01       Impact factor: 5.182

7.  Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor.

Authors:  J Nakai; R T Dirksen; H T Nguyen; I N Pessah; K G Beam; P D Allen
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

8.  Tissue-specific and developmentally regulated alternative splicing in mouse skeletal muscle ryanodine receptor mRNA.

Authors:  A Futatsugi; G Kuwajima; K Mikoshiba
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

9.  Relationship between nuclear magnetic resonance chemical shift and protein secondary structure.

Authors:  D S Wishart; B D Sykes; F M Richards
Journal:  J Mol Biol       Date:  1991-11-20       Impact factor: 5.469

10.  Measurement of calcium transients and slow calcium current in myotubes.

Authors:  J García; K G Beam
Journal:  J Gen Physiol       Date:  1994-01       Impact factor: 4.086

View more
  32 in total

1.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

Review 2.  Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.

Authors:  Nicole A Beard; Lan Wei; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-05-12       Impact factor: 1.733

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1.

Authors:  Fabio Esposito; Emiliano Cè; Susanna Rampichini; Elena Monti; Eloisa Limonta; Barbara Fossati; Giovanni Meola
Journal:  Eur J Appl Physiol       Date:  2017-02-14       Impact factor: 3.078

Review 5.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

6.  Unexpected dependence of RyR1 splice variant expression in human lower limb muscles on fiber-type composition.

Authors:  Hermia Willemse; Angelo Theodoratos; Paul N Smith; Angela F Dulhunty
Journal:  Pflugers Arch       Date:  2015-10-06       Impact factor: 3.657

7.  Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functions.

Authors:  Amy E Brinegar; Zheng Xia; James Anthony Loehr; Wei Li; George Gerald Rodney; Thomas A Cooper
Journal:  Elife       Date:  2017-08-11       Impact factor: 8.140

8.  The elusive role of the SPRY2 domain in RyR1.

Authors:  HanShen Tae; Lan Wei; Hermia Willemse; Shamaruh Mirza; Esther M Gallant; Philip G Board; Robert T Dirksen; Marco Giovani Casarotto; Angela Dulhunty
Journal:  Channels (Austin)       Date:  2011-03-01       Impact factor: 2.581

9.  Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.

Authors:  Aymeric Ravel-Chapuis; Ali Al-Rewashdy; Guy Bélanger; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

Review 10.  Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor.

Authors:  Hanshen Tae; Marco G Casarotto; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-04-28       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.